Antibody-fusion protein conjugates
CL202600275A1Pending Publication Date: 2026-07-03SIXPEAKS BIO AG
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- CL202600275
- Authority / Receiving Office
- CL · CL
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-07-31
- Filing Date
- 2026-01-29
- Publication Date
- 2026-07-03
Abstract
The present invention relates to immunoglobulins, such as immunoconjugates, comprising an ActRII receptor antibody and a GLP-1 agonist molecule, such as a GLP-1 agonist peptide. Such constructs are useful in the treatment of numerous diseases and disorders, including metabolic disorders such as obesity, diabetes, and others.
Need to check novelty before this filing date? Find Prior Art